Alaunos Therapeutics reported $-1.19M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Alaunos Therapeutics USD -1.19M 432K Sep/2025
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Biogen USD 659.6M 192.2M Sep/2025
Bioline Rx USD -2.21M 96K Sep/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Celltrion KRW 301.04B 58.57B Sep/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Curis USD -12.51M 40K Jun/2024
Deva Holding AS TRY 964.87M 240.32M Sep/2023
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Divis Laboratories Ltd INR 7.72B 30M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Incyte USD 383.88M 47.43M Dec/2025
Intrexon USD -60.84M 26.62M Jun/2024
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Karyopharm Therapeutics USD -31.28M 5M Dec/2024
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Malin Corporation EUR -1.1M 400K Dec/2024
Medical Developments International AUD -480K 662K Jun/2025
Merck USD 6.24B 318M Dec/2025
Neuren Pharmaceuticals AUD 5.45M 171.24M Jun/2025
Novartis USD 4.5B 363M Sep/2025
Organigram Holdings CAD -28.05M 7.76M Sep/2025
Ovoca Bio EUR -5.65M 3.45M Jun/2022
Pfizer USD 4.65B 3.99B Dec/2025
Pharma Mar EUR -3.96M 28.06M Sep/2025
PTC Therapeutics USD -81.62M 85.11M Dec/2025
Qiagen NV USD 121.88M 15.41M Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
Sartorius EUR 150.1M 11.7M Sep/2025
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
TG Therapeutics USD 29.36M 5.48M Sep/2025
Tilray USD -20.01M 9.34M Sep/2025
Verastem USD -18.28M 9.78M Jun/2024
Zz Pientze Pharmaceu CNY 501.33M 52.54M Sep/2025